University General Hospital of Larissa | Oncology Clinic - Clinical Trials Unit

Research site
Building 3 1st Floor, Larissa, Thessaly, Greece
Site insights

Top conditions

Breast Cancer (8 trials)

Type 2 Diabetes Mellitus (5 trials)

Diabetes Mellitus (5 trials)

Communicable Diseases (4 trials)

Infections (4 trials)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


28 of 57
Status: Active
Trial type: Interventional
Funder type: Industry

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with end...

Early Breast Cancer
Drug: Endocrine Therapy of Physician's Choice
Drug: Abemaciclib

This Phase III, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus everolimus compared with the phy...

Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
Drug: Dexamethasone Mouth Rinse
Drug: LHRH Agonist

The main purpose of the study is to evaluate the efficacy of vixarelimab compared with placebo on lung function in participants with idiopathic pulmo...

Systemic Sclerosis With Lung Involvement
Idiopathic Pulmonary Fibrosis
Drug: Vixarelimab
Drug: Placebo

A study designed to evaluate the safety of crovalimab with eculizumab in participants with PNH currently treated with complement inhibitors. This stu...

Paroxysmal Nocturnal Hemoglobinuria
Drug: Crovalimab
Drug: Eculizumab

Brigatinib is a medicine that binds to the surface of tumor cells in some cancers and delivers a dose of chemotherapy directly to the tumor. In this...

Active, not recruiting
ALK+ Advanced NSCLC
Drug: Brigatinib
Drug: Alectinib

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Breast Neoplasms
Drug: Letrozole
Drug: Tamoxifen

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy, and how well imlunestrant with abemaci...

Neoplasm Metastasis
Breast Neoplasms
Drug: Exemestane
Drug: Imlunestrant

This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult part...

Active, not recruiting
Drug: Orforglipron
Drug: Placebo

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Drug: Placebo
Drug: Tirzepatide

The primary objectives of this study are to assess the safety, tolerability, and pharmacokinetics (PK) of cefiderocol after single-dose administratio...

Ventilator Associated Bacterial Pneumonia (VABP)
Complicated Urinary Tract Infection (cUTI)
Drug: Standard of Care
Drug: Cefiderocol

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Systemic Lupus Erythematosus
Other: Placebo
Drug: Deucravacitinib

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.

Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Researchers are looking for a better way to prevent an ischemic stroke which occurs when a blood clot travelled to the brain in people who within the...

High-risk Transient Ischemic Attack
Acute Non-cardioembolic Ischemic Stroke
Drug: Placebo
Drug: Asundexian (BAY2433334)

The primary objective of this study is to evaluate the effect of setanaxib on alkaline phosphatase (ALP) at Week 24 in participants with PBC and with...

Active, not recruiting
Liver Stiffness
Primary Biliary Cholangitis
Drug: Placebo
Drug: Setanaxib

Study 849-017 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemothera...

Advanced NSCLC
Metastatic Lung Cancer
Drug: Adagrasib oral dose of 400 mg twice daily tablets
Combination Product: Pembrolizumab

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for...

Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: Masitinib (4.5)

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Idiopathic Pulmonary Fibrosis
Drug: Placebo
Drug: Deupirfenidone

This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy/performance and safe...

Locally Advanced Head and Neck Squamous Cell Carcinoma
Radiation: Radiation Therapy
Drug: NBTXR3

The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared wi...

Active, not recruiting
Leukemia, Myeloid, Acute
Leukemia, Myelomonocytic, Chronic
Drug: Pevonedistat
Drug: Azacitidine

Trial sponsors

Lilly logo

Lilly (10 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems